Skip to main content

$3 Million Additur Granted in an Asbestos Verdict

$3 Million Additur Granted in an Asbestos Verdict

$3 Million Additur Granted in an Asbestos Verdict

Introduction

In an order submitted on September 14, the New York Supreme Court, Appellate Division, First Department confirmed a trial court's order granting additur in a 2017 asbestos case. The past and future pain and suffering damages have been increased from $3.8 million to $6.5 million.

The order affirmed that there was adequate evidence on the plaintiffs' side from which the jury could analyze that the defendant knowingly hid asbestos exposure risks from the workers.

Asbestos exposure has been linked to mesothelioma, which is a rare form of cancer affecting the lungs, skin, stomach, and heart. Several construction place workers and manufacturing plant workers have filed lawsuits against companies for failing to warn them about asbestos exposure hazards.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.